https://www.oncopost.it/news-oncologia/hello-world/2023-10-08T05:04:23+00:00https://www.oncopost.it/approfondimenti/le-malattie-autoimmuni/2023-10-07T06:57:03+00:00https://www.oncopost.it/aggiornamenti-scientifici/tumore-al-seno/2023-10-17T08:23:06+00:00https://www.oncopost.it/aggiornamenti-scientifici/la-chemioterapia-come-cura/2023-10-17T08:23:02+00:00https://www.oncopost.it/approfondimenti/sostenere-la-ricerca/2023-10-17T08:23:15+00:00https://www.oncopost.it/news-oncologia/congresso-oncologico/2023-10-17T08:23:23+00:00https://www.oncopost.it/news-oncologia/i-centri-oncologici/2023-10-07T06:53:25+00:00https://www.oncopost.it/aggiornamenti-scientifici/limportanza-di-vaccinarsi/2023-10-07T06:53:16+00:00https://www.oncopost.it/approfondimenti/lotta-al-covid-19/2023-10-07T06:55:00+00:00https://www.oncopost.it/aggiornamenti-scientifici/la-sospensione-del-trattamento-endocrino-non-aumenta-i-rischi-di-recidiva/2024-08-01T13:40:14+00:00https://www.oncopost.it/aggiornamenti-scientifici/pembrolizumab-e-enfortumab-combinati-modificano-la-storia-dei-tumori-uroteliali/2024-08-01T13:40:10+00:00https://www.oncopost.it/news-oncologia/lo-studio-keynote-522-determina-una-practice-changing/2024-08-01T13:39:11+00:00https://www.oncopost.it/aggiornamenti-scientifici/europa-5-con-diagnosi-da-cancro/2024-08-01T13:38:24+00:00https://www.oncopost.it/aggiornamenti-scientifici/un-clade-di-fusobacterium-nucleatum-domina-il-cancro-del-colon-retto/2024-08-01T13:34:09+00:00https://www.oncopost.it/aggiornamenti-scientifici/le-sigarette-elettroniche-possono-contribuire-allo-sviluppo-di-tumori/2024-08-01T13:35:38+00:00https://www.oncopost.it/aggiornamenti-scientifici/la-sindrome-mano-piede-hfs/2024-08-01T13:35:05+00:00https://www.oncopost.it/approfondimenti/limportanza-del-care-giver-per-alleviare-la-solitudine-del-paziente-anziano/2024-08-01T13:36:53+00:00https://www.oncopost.it/approfondimenti/buona-tollerabilita-del-trattamento-prolungato-con-daralutamide/2024-08-01T13:36:10+00:00https://www.oncopost.it/news-oncologia/over-75-cure-multidisciplinari/2024-08-01T13:37:41+00:00https://www.oncopost.it/aggiornamenti-scientifici/fda-approva-il-rybrevant-per-il-cancro-del-polmone-avanzato/2024-11-11T15:34:50+00:00https://www.oncopost.it/aggiornamenti-scientifici/limportanza-del-test-brca-per-la-popolazione-maschile/2024-11-11T15:33:50+00:00https://www.oncopost.it/aggiornamenti-scientifici/osimertinib-approvato-per-il-cancro-del-polmone-non-a-piccole-cellule/2024-11-20T11:28:27+00:00https://www.oncopost.it/aggiornamenti-scientifici/esiste-una-associazione-tra-la-risposta-patologica-e-la-sopravvivenza-libera-da-malattia-nella-carcinoma-epatocellulare-dopo-trattamento-neoadiuvante-con-checkpoint-inibitori/2024-11-20T11:30:56+00:00https://www.oncopost.it/aggiornamenti-scientifici/ischemia-cardiaca-da-inibitori-dellaromatasi-in-pazienti-in-postmenopausa-con-carcinoma-mammario-iniziale/2024-11-29T10:48:00+00:00https://www.oncopost.it/aggiornamenti-scientifici/tumori-uroteliali-limportanza-dei-biomarkers-predittivi/2024-11-29T10:49:00+00:00https://www.oncopost.it/aggiornamenti-scientifici/ruolo-degli-acidi-grassi-nel-controllo-del-cancro-della-prostata/2024-12-19T17:22:31+00:00https://www.oncopost.it/aggiornamenti-scientifici/rischio-di-cancro-incidente-e-uso-di-inibitori-del-fattore-di-necrosi-tumorale-tnfi-non-tnfi-o-inibitori-della-janus-chinasi-jaki-in-pazienti-con-artrite-reumatoide/2024-12-19T17:24:19+00:00https://www.oncopost.it/aggiornamenti-scientifici/caraco-trial-e-possibile-omettere-la-linfoadenectomia-retroperitoneale-di-linfonodi-non-sospetti-in-corso-di-chirurgia-citoriduttiva-primaria-e-dintervallo-nelle-pazienti-con-carcinoma-ovari/2025-02-18T08:25:19+00:00https://www.oncopost.it/aggiornamenti-scientifici/studio-ameera-3-il-ruolo-di-amcenestrant-nel-carcinoma-mammario-avanzato-er-positivo-her2-negativo/2025-03-05T13:42:16+00:00https://www.oncopost.it/aggiornamenti-scientifici/il-valore-della-cessazione-tabagica-nei-pazienti-oncologici/2025-03-05T13:46:34+00:00https://www.oncopost.it/aggiornamenti-scientifici/chi-ha-paura-dellintelligenza-artificiale-ia-in-oncologia/2025-03-05T13:50:46+00:00https://www.oncopost.it/aggiornamenti-scientifici/chemoradiotherapy-and-subsequent-immunochemotherapy-as-conversion-therapy-in-unresectable-locally-advanced-esophageal-squamous-cell-carcinoma-a-phase-ii-nexus-1-trial/2025-03-11T11:39:06+00:00https://www.oncopost.it/aggiornamenti-scientifici/dose-exposure-relationship-of-exercise-and-distant-recurrence-in-primary-breast-cancer/2025-03-11T13:38:39+00:00https://www.oncopost.it/aggiornamenti-scientifici/caraco-trial-e-possibile-omettere-la-linfoadenectomia-retroperitoneale-di-linfonodi-non-sospetti-in-corso-di-chirurgia-citoriduttiva-primaria-e-dintervallo-nelle-pazienti-con-carcinoma-ovari-2/2025-03-11T13:42:27+00:00https://www.oncopost.it/aggiornamenti-scientifici/parliamo-di-oblio-oncologico/2025-03-17T10:34:20+00:00https://www.oncopost.it/aggiornamenti-scientifici/immunoterapia-e-mesotelioma-un-sogno-che-puo-diventare-realta/2025-03-17T10:39:26+00:00https://www.oncopost.it/aggiornamenti-scientifici/melanoma-in-eta-pediatrica-efficacia-e-attivita-degli-anticorpi-anti-pd-1/2025-03-17T10:41:58+00:00https://www.oncopost.it/aggiornamenti-scientifici/diabete-mellito-e-cancro-link-patogenetici-e-terapeutici/2025-03-24T09:41:37+00:00https://www.oncopost.it/aggiornamenti-scientifici/ramucirumab-e-pembrolizumab-nei-tumori-squamosi-della-testa-e-collo-una-nuova-possibilita/2025-03-31T10:44:52+00:00https://www.oncopost.it/aggiornamenti-scientifici/confronto-tra-radioterapia-ipofrazionata-e-radioterapia-convenzionale/2025-04-01T09:42:41+00:00https://www.oncopost.it/aggiornamenti-scientifici/lo-screening-dei-tumori-migliora-il-tasso-di-diagnosi-iniziale-dei-tumori/2025-04-09T13:06:03+00:00https://www.oncopost.it/aggiornamenti-scientifici/confronto-tra-la-colonscopia-e-la-ricerca-immunochimica-del-sangue-occulto-nelle-feci-quale-screening-oncologico/2025-04-18T09:28:48+00:00https://www.oncopost.it/aggiornamenti-scientifici/efficacia-di-un-trattamento-prolungato-di-anticoagulante-orale-nella-prevenzione-degli-eventi-tromboembolici-e-nella-riduzione-del-sanguinamento/2025-04-28T08:56:42+00:00https://www.oncopost.it/aggiornamenti-scientifici/ruolo-della-risonanza-magnetica-nello-screening-oncologico/2025-06-03T13:55:13+00:00https://www.oncopost.it/approfondimenti/lolanzapina-e-efficace-per-il-controllo-dellemesi-da-carboplatino/2025-06-19T13:42:02+00:00https://www.oncopost.it/approfondimenti/pembrolizumab-in-prima-linea-di-trattamento-nel-melanoma-metastatico-a-10-anni-di-lo-studio-keynote-006-si-conferma-una-miniera-di-informazioni-fondamentali/2025-06-19T13:46:39+00:00https://www.oncopost.it/approfondimenti/il-ruolo-del-cetuximab-dopo-immunoterapia-nei-tumori-squamosi-della-testa-e-del-collo-recidivati-metastatici-dopo-immunoterapia-una-domanda-ancora-senza-risposta/2025-06-19T13:51:40+00:00https://www.oncopost.it/news-oncologia/vantaggi-dellimpiego-di-gabapentinoidi-nel-glioblastoma/2025-07-02T10:27:13+00:00https://www.oncopost.it/aggiornamenti-scientifici/indice-di-massa-corporea-attivita-fisica-e-rischio-di-sviluppare-un-tumore-in-pazienti-lungoviventi-dopo-un-tumore-in-eta-infantile/2025-07-16T13:31:54+00:00https://www.oncopost.it/news-oncologia/short-communication-simultaneous-removal-of-co-occurring-contaminants-reduces-drinking/2025-08-06T11:08:14+00:00https://www.oncopost.it/approfondimenti/diabetes-and-colorectal-cancer-risk-and-survival-according-to-tumor-immunity-status/2025-10-14T09:16:22+00:00https://www.oncopost.it/approfondimenti/medical-imaging-and-pediatric-and-adolescent-hematologic-cancer-risk/2025-10-14T09:20:39+00:00https://www.oncopost.it/news-oncologia/association-of-social-vulnerability-with-access-to-treatment-in-ovarian-cancer-patients/2025-11-06T11:43:43+00:00https://www.oncopost.it/news-oncologia/comprehensive-analysis-of-the-systemic-immune-landscape-across-breast-cancer-subtypes-and-disease-stages/2025-11-06T11:51:19+00:00https://www.oncopost.it/aggiornamenti-scientifici/timing-and-combinations-of-cardiovascular-diseases-in-survivors-of-childhood-adolescent-and-young-adulthood-cancer/2025-11-14T13:32:38+00:00https://www.oncopost.it/aggiornamenti-scientifici/statin-use-in-patients-with-cancer-drug-interaction-and-statin-usage/2025-11-14T13:40:25+00:00https://www.oncopost.it/news-oncologia/emerging-evidence-for-sequencing-and-combining-psmabased-therapies-in-prostate-cancer/2025-11-27T10:23:38+00:00https://www.oncopost.it/news-oncologia/myeloid-metabolism-and-its-role-in-immunotherapy-of-cancer/2025-11-27T10:26:00+00:00https://www.oncopost.it/aggiornamenti-scientifici/mathematical-and-computational-nuclear-oncology-toward-optimized-radiopharmaceutical-therapy-via-digital-twins/2025-12-19T11:25:56+00:00https://www.oncopost.it/aggiornamenti-scientifici/177lu-prostate-specific-membrane-antigen-neoadjuvant-to-stereotactic-ablative-radiotherapy-for-oligorecurrent-prostate-cancer-lunar-an-open-label-randomized-controlled-phase-ii-study/2025-12-19T11:28:48+00:00https://www.oncopost.it/aggiornamenti-scientifici/artificial-intelligence-entering-the-pathology-arena-in-oncology-current-applications-and-future-perspectives/2025-12-19T11:31:49+00:00https://www.oncopost.it/aggiornamenti-scientifici/glp-1-receptor-agonists-in-breast-cancer-a-new-frontier-in-obesity-and-prognosis-management/2025-12-19T11:36:57+00:00https://www.oncopost.it/news-oncologia/20th-anniversary-of-adjuvant-trastuzumab-reflections-on-a-breakthrough-moment/2025-12-23T11:52:28+00:00https://www.oncopost.it/news-oncologia/rp1-combined-with-nivolumab-in-advanced-anti-pd-1-failed-melanoma-ignyte/2025-12-23T11:55:19+00:00